Biomarker Research Services Market to See Booming Growth 2021-2028 | Noble Life Sciences, Inc., Reprocell Corporation, Coriell Institute

Biomarker Research Services Market to Surpass US$ 18.2 Billion Threshold by 2026 - Coherent Market Insights

The global biomarker research services market is expected to witness significant growth over the forecast period. The market growth is attributed to factors such as increasing number of collaborations and partnerships, mergers and acquisitions, and product launches by key players. Furthermore, factors such as increasing application of biomarkers, and increasing usage of companion diagnostics for personalized medicine are further expected to fuel growth of the global biomarker research services market over the forecast period. For instance, in May 2019, BioIVT joined the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium. The FNIH Biomarkers Consortium is a public-private biomedical research partnership. It brings together members of industry, academia, nonprofit and patient advocacy organizations, and government agencies and institutes to develop and support research to qualify promising biomarkers for disease diagnosis, predicting therapeutic response, and improving clinical practice.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/2612

Furthermore, in 2017, BioIVT acquired Asterand Bioscience, a global provider of high quality, well-characterized human tissue, and research solutions, with a focus on the oncology market. Asterand Bioscience focuses on drug research by accelerating target identification and biomarker validation and improving drug candidate selection to increase the likelihood of clinical success.

Browse 26 Market Data Tables and 32 Figures spread through 178 Pages and in-depth TOC on Global Biomarker Research Services Market by Service Type (Biomarker Research Services, and CDx Research Services), by Disease Indication (Oncology, Cardiovascular Disorder, Infectious Disease, Neurological Disorder, Immunological Disorder, and Others), by End User (Hospitals, Specialty Clinics, and Diagnostic Centers) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2026

Additionally, in 2017, REPROCELL Corporation formed an alliance with Fox Chase Medical Center (Philadelphia, U.S.) to accelerate biomarker and genetic discovery. Through this alliance, REPROCELL Corporation focused on augmenting its global repository of bio-specimens with samples from the Fox Chase Cancer Center and ensured that researchers had access to a wide array of clinical-grade bio-specimens. Moreover, in 2017, Bristol-Myers Squibb Company and Nordic Bioscience A/S entered into a collaboration agreement to develop biomarker technology to potentially aid the diagnosis and monitoring of fibrotic diseases including non-alcoholic steatohepatitis (NASH). Similarly, Nordic Bioscience S/A received CE marking for its PRO-C3 assay, in 2017. This is part of the company’s regulatory efforts to support biomarker use in clinical research. The marking signifies that the measurement of PRO-C3 is of high quality, and is regulated in a correct manner.

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/2612

Key Takeaways of the Global Biomarker Research Services Market:

• The global biomarker research services market is expected to exhibit a CAGR of 13.5% over the forecast period (2018–2026), attributed to rising prevalence of diseases and rising need for early diagnosis. For instance, according to the National Cancer Institute, 2016, around 16.8 million new cases of cancer were diagnosed in the U.S. with around 595,690 deaths from the disease. The number of people with cancer is expected to increase up to 19 million by 2024.

• Key players are focusing on employing contract research organizations for research and development of biomarkers, which is expected to drive the market growth over the forecast period.

• Among service type, companion diagnostic research services segment is expected to witness significant growth over the forecast period

• Key players operating in the global biomarker research services market include Noble Life Sciences, Inc., Reprocell Corporation, Coriell Institute, BioIVT, ICON Plc., SRI International, Inc., Charles River Laboratories, Inc., Nordic Bioscience A/S, Proteome Sciences Plc., and Covance Inc. (Laboratory Corporation of America Holdings, Inc.)

To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/2612

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.